DUBLIN, Apr. 14, 2014 /PRNewswire/ --
Research and Markets
) has announced the addition of the
report to their offering.
The analysts forecast the Global Next Generation Sequencing market to grow at a CAGR of 20.78 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased adoption of next generation sequencing by new customers. The Global Next Generation Sequencing market has also been witnessing an introduction of new DNA sequencing products and accessories. However, the logistical problems could pose a challenge to the growth of this market.
The report, Global Next Generation Sequencing Market Report, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Next Generation Sequencing market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
With the expansion of the customer base to less sophisticated customers, access to improved bioinformatics tools is becoming even more of a priority. Sequencing companies started to seriously tackle this issue: in 2012 Life Technologies unveiled Ion Reporter, a commercial cloud-based variant analysis software package and purchased Compendia Bioscience.
Illumina launched BaseSpace Apps, a dedicated application store for BaseSpace, its genomics cloud computing platform. In addition, Illumina secured the buy-in of bioinformatics companies such as Golden Helix, Biomatters, Ingenuity, Station X, and Spiral Genetics, on top of collaborations with Diagnomics, Ingenuity, and Knome.
According to the report, the growth of the Global Next-generation Sequencing market is driven by several factors, the most important of which is the increased adoption of next-generation sequencing technology by new customers.
Further, the report states that one of the key challenges in the market is the low adoption of genomic technology compared to other sequence analysis technologies, especially among large biotechnology companies. This is mainly because of logistical problems such as instrument complexity, problems in data storage, automation, and sample preparation.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Key Topics Covered:
1. Executive Summary
2. Scope of the Report
3. Market Research Methodology
4. List of Abbreviations
6. Market Landscape
7. Market Segmentation by Application
8. Market Segmentation by Technology
9. Market Segmentation by Product
10. Market Segmentation by End-users
11. Geographical Segmentation
12. Key Leading Countries
13. Buying Criteria
14. Market Growth Drivers
15. Drivers and their Impact
16. Market Challenges
17. Impact of Drivers and Challenges
18. Market Trends
19. Trends and their Impact
20. Vendor Landscape
21. Key Vendor Analysis
22. Other Reports in this Series
- 23andMe Inc.
- Ambry Genetics Corp.
- Axeq Technologies Inc.
- Beijing Genomics Institute
- Fluidigm Corp.
- Foundation Medicine Inc.
- Good Start Genetics Inc.
- Helicos BioSciences Corp.
- Illumina Inc.
- Knome Inc.
- Life Technologies Corp.
- NABsys Inc.
- Oxford Nanopore Technologies Ltd.
- Pacific Biosciences of California Inc.
- Pathogenica Inc.
- QIAGEN N.V
- RainDance Technologies Inc.
- Roche Holding AG
- Sequenom Inc.
- Takara Bio Inc.
For more information visit http://www.researchandmarkets.com/research/znls9v/global_nex
Laura Wood , +353-1-481-1716, email@example.com
SOURCE Research and Markets